Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Home
Experts
Research units
Cores
Projects
Research output
Prizes
Search by expertise, name or affiliation
Chemotherapy resistance in breast cancer
Polly A. Niravath
, Julie Nangia
Academic Institute
Department of Medicine
Dr. Mary and Ron Neal Cancer Center
Houston Methodist
Weill Cornell Medical College
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Chemotherapy resistance in breast cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Antimetabolites
100%
Taxoids
96%
Anthracyclines
84%
Tubulin
80%
Microtubules
72%
taxane
63%
Breast Neoplasms
47%
Drug Therapy
43%
Glycoproteins
42%
eribulin
40%
lysosomal proteins
36%
Superhelical DNA
36%
Type II DNA Topoisomerase
32%
Capecitabine
31%
tau Proteins
31%
Pharmaceutical Preparations
30%
Genes
30%
Phase III Clinical Trials
29%
Microtubule-Associated Proteins
29%
Apoptosis Regulatory Proteins
29%
Gene Amplification
29%
Drug Design
28%
Docetaxel
27%
Proxy
26%
Paclitaxel
25%
DNA Replication
24%
Cell Cycle Checkpoints
24%
Permeability
21%
Protein Isoforms
20%
Neoplasms
16%
Apoptosis
15%
Cell Line
14%
Recurrence
14%
Therapeutics
4%